Dear Reader,

In a few months, a tiny Miami-based company plans to go “public” with the biggest consumer product breakthrough of the 21st century…

The man behind this product is one of America’s top business minds… an entrepreneurial genius (and medical doctor) in Florida I’ll call Phil Summers who, until recently, was very wealthy and very bored.

You’ve probably never heard of this man before...

Which is a shame, because Phil has a knack for starting out with a very simple business idea — and reliably using this idea to generate literally hundreds of millions of dollars per year.

He got rich (the first time) by starting a small company in 1972, which he sold in 1986 for a personal share of $100 million.

Yup. $100 million in a single day!

You’d think that would be enough of a payout for someone to hang it up and retire comfortably.

But not for Phil!

He immediately got right into another startup business, built it up and then sold his second venture to another company in 2005.

This second deal put $1.1 billion in his pocket.

You’d think THAT would be enough…

But not for Phil!

Maybe it’s an addiction. Maybe he has a “Steve Jobs” type of personality…

Whatever his motivation, Phil is relentless in making money using his simple idea…

He finds an early-stage company that has extremely valuable products with huge mass appeal…

Then he invests his own money to acquire a controlling stake…

Then he will do what it takes to ensure the product reaches a mass market…

And then… after achieving massive success… Phil will get bored and sell off the company to a huge corporation for a huge payout for early investors.

Remember, Phil’s already done it twice before.

Now Phil’s given every indication that he plans to do this exact same thing AGAIN with the tiny Miami-based company I want to show you today…

This truly is a one-time chance to invest alongside one of America's top entrepreneurial minds. But it is fit for serious readers ONLY!

Imagine finding a new product everyone on Earth will desire…

Imagine seeing this product in every home in America in the very near future — as ubiquitous as televisions or smartphones or washing machines…

Then imagine getting in on THE GROUND FLOOR… where early-stage investors could triple their money in a single day… or make as much as an incredible 17,895% over a longer term…

Do these kinds of explosive investment opportunities really exist?

OF COURSE!

But in almost all cases, these opportunities only exist for a short window of time… to small groups of investors… and you need to move very FAST before they disappear forever…

So please, please pay attention to every word I have for you today…

We don’t have a lot of time… the clock is ticking… and already word has leaked out to the mainstream press…

• The Wall Street Journal reviewed a prototype of Phil’s new product for the paper’s highly coveted “Innovation Awards.”

• Phil’s company has a contract with NASA to provide a prototype of his product to astronauts aboard the International Space Station.

• And the company Phil recently acquired was recognized as one of the 50 Most Innovative Companies in the World by MIT Technology Review…

In the next 90 days, we’re expecting an unprecedented and shocking announcement from Phil’s newest company…

When this news hits the mainstream media, I believe it could become the most talked about technology breakthrough of our lifetimes.

And more than that, Phil’s newest venture is almost certain to generate millions in investment profits for early-stage investors…

But I need to be upfront and tell you that investing in early-stage companies like these — even those backed by a certified business genius like Phil — can be risky and is not for everyone.

While this company is by no means a penny stock, it’s pretty small when compared to its top industry competitors.

The fact is this is probably only appropriate for about the top of 1% of our readers... which is why we are going to limit the number of people who get the details from us.

No, you do NOT need to be an accredited investor to get in on this.

But yes, I am going to assume you have a certain level of knowledge about making money from early-stage investments and move very quickly from here out…

That’s why if you’d rather be safe than have the real chance to strike it rich, I am going to ask you to click away from this page now…

Still here? Good! You’re about to go on an adventure of a lifetime as I show you everything I’ve discovered about Phil’s latest project…

The Secret to Making $100 Million
in a Single Day

My name, by the way, is Ray Blanco…

I’m the chief technology analyst for Agora Financial.

We’re one of the largest fully independent market research organizations in the world today.

More people read our information each week, for example, than receive newspapers like The Washington Post or The Los Angeles Times.

What I do is simple…

My goal is to find the biggest early-stage moneymaking opportunities in technology — and put them on a silver platter for my readers.

In short, this latest venture being launched by Phil Summers could be the most exciting opportunity I’ve ever found…

As I said before, Phil started his career as a medical doctor. And a darn good one too…

In fact, at the young age of 34, Phil became the head of the dermatology department at Mount Sinai Medical Center in Miami Beach.

But Phil was never content with medicine. In fact, it bored him to tears!

Besides, Phil had a wife and growing family — he needed money, fast!

And that’s where Phil figured out an amazingly simple moneymaking secret…

“What’s something every human being on Earth must have?” he asked himself…

What is the one thing that keeps all 7 billion of us on Earth up a night?

The answer might surprise you, because it’s so simple.

But what Phil discovered is that the one thing we all need is… our health.

Once Phil figured out this out, he set out to find and sell the best products to tap into this universal desire.

And it didn’t take long until Phil had taken all of his savings and ploughed them into a struggling drugmaker.

Why? Because he found out this drugmaker had a very effective asthma medication on their hands… something that could help millions of people improve their health.

But even with a potential blockbuster product on their hands, this company couldn’t get the necessary government approvals they needed to market the product.

So Phil took over the company, helped get the government approvals to commercialize and take this product to the public — and transformed this asthma medication into a very successful product.

In fact, at one point, Phil’s product became the leading drug for asthma in the country.

Phil later sold his drugmaker company to a New Jersey pharmaceutical giant for $800 million. (This is the same deal I told you about earlier, the one that paid Phil his first $100 million payday.)

Of course Phil wasn’t done yet! No way, José!

In fact, Phil spent the next 40+ years looking for the ULTIMATE health product with mass consumer appeal…

And then, just a few years ago, he finally found it…

The ULTIMATE Health Consumer Product

Imagine a few years from now, you start feeling a little sick.

Maybe you feel the “the sniffles” coming on. Maybe you worry it’s something worse…

You walk up to a toaster-sized machine in your home.

You stick your finger into a slot. Push a button.

And out of the machine comes the key to a “cure” for your illness...

OK, this might sound like science fiction, like something you’d see on Star Trek or The Jetsons…

But I’m here today to tell you this kind of machine already exists.

And not only is this “Universal Cure Machine” technology real…

….but the tiny Miami-based company run by Phil Summers now controls the key patents for this kind of technology!

Basically, Phil’s device works as a medical lab in a box… a fully functional lab that fits inside a toaster-like machine.

This is a HUGE development if you’ve ever been to the doctor to get bloodwork…

You might remember how it works now. You go in and wait for your appointment, the doctor takes your blood — and you then have to wait (sometimes days) to get the results.

And if you are worried you might have a SERIOUS, life-threatening disease (such as cancer) then every hour you wait for your test results feels like a week…

…and every day you wait feels like months.

According to one of the largest medical testing companies, it takes at least 24 hours from receiving a sample for the lab to get the results.

Right now certain tests take several days, or even weeks, for results.

And even when the lab gets the results, it doesn’t send them directly to you.

Instead, the lab is only required to send your test results to the ordering health care provider, such as your doctor’s office.

As a result, you are totally dependent on your doctor’s office to share your results.

That is, of course, if your doctor even bothers to tell you at all…

In fact, according to a New York Times investigation, several studies have shown that doctors delay or fail to notify patients of as many as 36% of abnormal test results, including possible malignancies!

And if waiting around wasn’t bad enough, getting blood tests from the lab can be incredibly expensive…

If you have insurance, your total billed costs for simple bloodwork at a lab can cost as much as $1,200.

If you do not have insurance, your total out of pocket costs could be as much as $3,000 or more, depending on the number and type of tests ordered, the cost of any doctor visits to order and interpret the tests, and whether the tests are done on an emergency basis.

In an eye-opening report published in the journal BMJ Open, some California hospitals charge as much as $10,169 for a cholesterol test…

Meanwhile, the product Phil’s tiny company in Miami developed is so much better and cheaper for consumers!

A Quantum Leap in On-Site and Point-of-Care Diagnostic Technology

This means astronauts are using this tiny company’s product right now, miles above the Earth, to manage their health. The reason why is because this machine works…

Lab Tests at Home for Only $1 a Test?

In fact, not only can you get your results FAST from this machine, but you’ll get results as good as what you’d get from a lab.

For example, a few years ago, early prototypes of these “Universal Cure Machines” were tested in Rwanda as part of a humanitarian effort to reduce the spread of HIV/AIDS.

According to results published in Nature Medicine, this device detected 100% of cases when used to test HIV.

And with syphilis and HIV together, a more complicated test, it reported only a 4–6% false positive rate. This very small number is the same as results you’d get from standard lab tests in the developed world.

Of course, most Americans won’t be using this machine to detect AIDS in Africa...

My point is Phil’s “Universal Cure Machine” has already proven itself safe and reliable under some of the most challenging circumstances you can imagine, from inside the International Space Station to the rugged plains of the Third World.

And in a few moments, I’m going tell you why Phil and his tiny company are about to get the ultimate “Gold Seal” needed to sell these devices to a mass market in the United States…

But before then, I want to tell you the best part for us as consumers…

Because not only can you get lab-quality results from this machine in less than 10 minutes… but you can get these fast results DIRT CHEAP.

The machine itself costs less than $100 to manufacture.

Compare that to the $100,000 you’d need to outfit a traditional medical lab!

And each cartridge costs only $1 to make.

The unit itself has no moving parts, which makes it extremely easy and cheap to manufacture on a mass scale.

As one of the developers behind this machine noted, “The majority of the technology is in chemistry built into the (cartridge) — it needs no heat, no electricity, no software.”

And remember, $1 is only the cost to manufacture the cartridge. That’s just the cost of goods and not the wholesale or retail price.

Remember as I said earlier, blood tests right now can sometimes cost as much as $1,200 per test…

So even if Phil’s company priced these cartridges for 12 times what it costs to make them, then we the consumers would still be getting a huge bargain at $12 per test, which could be 100 times cheaper than what these kinds of tests can cost…

But you might wonder... if this technology is so great, why can’t some large corporation swoop in and steal Phil’s company’s future market share?

And what’s the holdup in getting this product to the consumer markets?

The answer to both questions is hidden inside each plastic cartridge...

The Secret Hidden on Little Pieces of Plastic

Imagine a flat, clear piece of plastic, like a credit card...

This plastic surface is the “chip” that makes these cartridges work.

And printed on each chip are little hairline channels in geometric patterns, like this:

Well, what Phil’s design team figured out is something nobody on Earth ever thought of before…

They put tiny antibodies inside each channel of these chips to “sniff” out deadly disease.

It works like this:

1. First, you put a pinprick of your blood into the cartridge, where it flows onto a custom-made chip and spreads into the different channels…

2. Inside each channel, your blood interacts with the different antibodies, which “sniff” out pathogens and bind with metallic particles to create something called “biomarkers.”

3. Then you pop the cartridge into the device, where an optical scanner automatically reads the biomarkers — and in less than 10 minutes, gives you a readout of whatever it detects.

Now, this process might sound rather simple on paper…

But for years, scientists could not figure out how to get the blood to flow properly through these tiny little channels.

Then scientists from Columbia University figured out the science of what’s called “microfluidics” — and with this breakthrough secret, the technology behind the “Universal Cure Machine” was born.

And here’s the incredible news if you’re an early-stage investor:

Phil Summers and his tiny Miami-based company recently acquired THE KEY PATENTS for using microfluidics like this to detect disease.

This tiny company owns the patent for the optics technology on the device that reads the “biomarkers” created by the microfluidics.

It also owns the patent for using microfluidics on the chips…

Microfluidics is what makes a “Universal Cure Machine” possible… and Phil’s company now has a virtual monopoly over microfluidics in medicine.

This is a HUGE deal. Remember, owning the patents is the best “moat” against competitors you can get. So it will be very, very difficult for a company to “knock off” this product or steal the technology.

It also means that if another company wants access to Phil’s technology, they need to pay Phil’s company first to license it…

But licensing this technology, as easy and lucrative as it could be, is only the tip of the iceberg on this opportunity, because…

Starting in Only a Few Months, This Product Is Literally Going to Swamp the U.S. Market… Then the World!

Based on everything you know about Phil, you won’t be surprised if you see him use a very methodical strategy to mass commercialize his breakthrough product…

And what a market size he will have to tap into!

According to some estimates, the medical lab testing market alone is predicted to reach $241 billion in the near future.

Phil’s “Universal Cure Machine” product will easily disrupt this market since it is faster, better, cheaper and more convenient to use than traditional lab testing.

But then consider there are 854,698 doctors practicing in just the United States.

You can bet your bottom dollar every doctor in the country is going to want to have this machine in their practice… this machine will be as ubiquitous as stethoscopes.

But that’s just for starters…

For example, it’s already possible to hook your machine to the internet so your doctor can instantly review the results and give you a cure for your ailment “in real time.” Or even better, send YOU your results, directly to your cell phone.

The device could also be programed to give you instant answers to your most pressing health needs. Like a smartphone, new “apps” or upgrades could easily be added to the platform. The health possibilities for this device are endless!

In other words, what Phil’s device represents is NOT just a new kind of diagnostic device that will be used in doctors’ offices across the country…

What this device really represents is the start of what I believe could eventually become a new kind of home appliance — a “Universal Cure Machine” — that could soon be in every home in America.

How big of market would that be?

According to Nielsen, there are 116.4 million homes with televisions in the United States.

And if you can afford an HD television, you could easily afford Phil’s device once it is ready for the mass market.

But here’s the best part for Phil’s investors:

It is clear to me what Phil is really building is a “razor-razorblade” company… where he makes money not just when each machine (the razor) is sold, but is also guaranteed a stream of income from sales of disposable units (the razor blades).

Based on statistics from the Centers for Disease Control and Prevention, I estimate that 6.8 billion laboratory tests are performed in the United States annually…

Each of these tests could be sold as cartridges for Phil’s “Universal Cure Machine.”

So Phil could easily sell at least 6.8 billion cartridges per year…

If we price these tests at their current $1 cost, that’s $6.8 billion in annual sales right there.

Of course, Phil is going to mark them up at a decent profit margin.

So let’s say he marks them up to $10 a test, which is still a steal for most people.

Then this tiny company would be looking at $68 billion in annual cartridge sales alone…

Put the price up to $20 per test, and we’re up to $136 billion per year in sales…

At $136 billion in sales a year, Phil’s currently tiny company would be pulling in the same amount Apple brought in from sales of the iPhone in 2012.

Are you starting to see why this could be the ULTIMATE consumer product — especially for early-stage investors?

But it all hinges on a huge public event I’m expecting within the next 90 days…

The Huge “Public” Event That Will Unleash
This Breakthrough

In short, Phil and his company are now on the verge of getting the final stamp of approval from the U.S. government to market their device to a mass market.

For the last several years, Phil and his crack team of engineers, scientists and doctors have been running clinical trials proving to the U.S. Food and Drug Administration that this technology really works.

And only a few months from now, Phil expects they will get their first FDA approval for his testosterone diagnostic test utilizing the “Universal Cure Machine” system…

This U.S. government “Gold Seal” of consumer safety will be a HUGE event for early-stage investors in Phil’s company for two reasons:

First, this will be the U.S. government putting their “Gold Seal” on the product, letting everyone know the product is both safe and effective.

Mark my words: This FDA approval will be THE event that puts this company on the public’s radar screens forever!

And second, it’s been proven these kinds of regulatory approvals can substantially increase the market value of a company…

Consider the case of a company named Arena (ARNA), based in San Diego…

For weeks, its stock was considered “dead” to most traders.

But then, in January 2012, once the company got FDA approval on one of its treatments, ARNA started shooting upward, rising 567%...

Feast your eyes on what happened next…

In fact, if you’d put $10,000 in ARNA right before it started to take off, you would have ended up with $66,742 in your pocket…

Double your starting capital, and now you’re up to $133,484.

Then look at a company with the ticker AFFY.

If you had known in advance this was coming, you could have been there when this company received FDA approval for its products and it ran up 227.5% in eight months…

The point is I’ve never found any easier way for a company to instantly raise their market value than to simply get FDA approval to sell their medical products.

And I’ve never found an easier way for early-stage investors to get rich than to simply get into a company BEFORE they get these kinds of approvals.

And that is why I am trying to URGENTLY get you this information today…

Because all indications are Phil Summers and his tiny company based in Miami are poised to get FDA approval for their breakthrough product — in only a few months from today…

Remember, Phil’s done this before…

In 1972, he got FDA approval to sell an asthma medication and commercialized it under the brand name “Theo-Dur”... and eventually sold his first company for $800 million…

Then he did it with a second company just 10 years ago, getting FDA approvals to commercialize the country’s first generic time-release drug and the country’s first generic inhaler… and eventually selling this second company off in 2005 for $7.4 billion…

Which brings me to something else…

With a U.S. “Gold Seal” for Safety, This Company Becomes an Instant Acquisition Target

Once Phil’s company gets FDA approval for this first testosterone test, it immediately becomes an acquisition target for other, larger companies.

Remember, Phil is not just focused on this one testosterone test. He is focused on building the ultimate health consumer product. This means he will need cartridges for other tests.

Potentially, this could be anything you test for right now using bloodwork and a traditional medical lab.

But according to Phil, he’s focusing his efforts on what he probably considers the most lucrative markets first, including infectious disease, nephrology, cardiology and women’s health.

Factor in these long-term growth prospects, along with Phil’s track record of building up companies for acquisition… and it’s possible we could see a larger company buy out this tiny company…

And when that happens, shareholders could see the value of their investment double, or even triple, overnight!

Consider the story of Idenix Pharmaceuticals Inc. (IDIX)…

Right before it was bought out by pharma giant Merck & Co., IDIX was trading for $7.23 a share.

Merck’s purchase price for IDIX? $24.50 a share in cash.

That’s more than TRIPLE the original share price of IDIX.

Which means that IDIX shareholders who got in before the deal instantaneously made three times their money back, just by holding on to their shares…

On the other hand, maybe Phil won’t choose to cash in right away…

He might choose to let his tiny company grow up to be a “blue chip” household name, like Apple, Johnson & Johnson or Pfizer…

And once a medical company gets FDA approvals for its treatments, the returns you can see over the longer term will knock your socks off. For example:

• A company called Biogen developed a new multiple sclerosis treatment. Once it got the medicine approved by the FDA, Biogen’s early investors went on to pocket more than an amazing 8,496% return…

• Then there’s a medical company called Celgene… in the time since its cancer treatment received FDA approval, early investors have seen their stock shoot up an incredible 6,251%…

• There is a company called Amgen that got FDA approval for its human protein therapy. Amgen’s stock has now soared an astounding 17,895%. If you put only $10,000 in Amgen at the right time, you’d now be sitting on an incredible $1,789,500 in profits…

Of course these are some pretty exceptional gains. Not every company with an FDA-approved product will see them. But it just goes to show you what is possible…

You’ve Probably Got Questions

OK, I’m sure you’ve got a few questions at this point, so let’s quickly answer them:

No Medical or Trading Experience or
Knowledge Needed

As you may know, when it comes to the risky world of biotechs and medical stocks, any piece of news can send them soaring…

Take a company named Spherix Inc., for example.

They exploded up 310% in just six days after announcing their latest FDA trial results for a diabetes treatment called Naturlose.

Investors who got in early could’ve seen every $500 jump to $2,050… in a week!

Now look at Aquinox Pharmaceuticals…

When they announced positive Phase 2 results from the FDA on their drug to treat bladder pain, shares of their stock exploded 1,094% in a short five-day period.

Every $500 put up by investors turned into $5,970… in less than a week!

When Heron Therapeutics delivered positive results on their Phase 3 study of a drug to help those suffering from the side effects of chemo, their stock climbed 181% in just 18 days.

Check it out:

Again, investors who got in early would’ve seen every $500 turn into $1,390… in less than three weeks!

What this all means is that… when it comes to new biotech or medical device companies… there’s three things you must understand.

• First, it’s absolutely critical you get in early.

• Second, explosive gains can happen in as little as a single day… when positive news is released.

• Third, these kinds of opportunities are not for those who can’t tolerate risk…

Small stocks, as you know, can move up (and down) very quickly, so don’t invest money you can’t afford to lose.

But when they’re shot upward based on good news, like the news I’m expecting from Phil’s company, you can make enormous gains.

This is exactly what I aim to show you in a research service I run, called Agora Financial’s FDA Trader…

Dozens of companies pop up on my radar every month.

Most never get more than a few minutes of my time because I can quickly spot a red flag.

Maybe it’s a history of failed testing, sloppy research or just bad science.

The few companies that pass my review get a full examination...

I pore over the companies’ financials, science, potential market size, quality of company management… you name it.

That’s why, to follow my recommendations, you don’t need to be a doctor or scientist or anyone else in the field of medicine. I do all the dirty work for you.

Remember, Phil Summers and his “Universal Cure Machine” will revolutionize the field of medicine… it will save lives, and it will make life better for ALL of us, including you, me and every other American.

Never in history will average people (like you and me) have as much control over our health and the chance to live healthier and happier lives!

Once Phil’s product hits every doctor’s office in the country, you will see countless news stories about how this is the Next Big Consumer Product. And by then, all the chances to make big money as an investor will be gone.

Remember, I’m also predicting that in as soon as a few years, this product could be in every home in America…

And if this doesn’t get you excited as an investor, my friend, I’m not sure what will.

However, in order to have the chance at making the most money, you need to get into this tiny company right now, while its market capitalization remains relatively tiny.

So the big question is… are you in or out?

Because I’m willing to share with you my exclusive “prospectus,” The Secrets of Profiting From the Ultimate Health Consumer Product — but only if you act today… and give my FDA Trader research service a try.

Slots Will Fill Up Fast:
Here’s What You Need to Do Right Now
to Get Started

Listen…

Right now I want you to look at the bottom of your screen.

If you see a button that says “Subscribe Now,” then I have good news…

Some of this offer’s remaining slots to my service are still available.

If you’re interested in what I’ve laid out for you, I want you to simply click on the button.

You will then get instant access to my full write-up on the tiny biotech firm I’ve spent the past few months researching.

I will tell you everything you need to know in my “prospectus” called  The Secrets of Profiting From the Ultimate Health Consumer Product.

But remember — and this is CRITICAL — Phil’s company, compared to the major players in its industry, is still small… so only so many shares can be bought before the stock price starts to rise and the best opportunity is gone. Therefore  we need to limit how many people get this information today.

I wasn’t kidding earlier. This is an early-stage opportunity good for serious investors only. That’s why when it comes to my service, I have no time for tire kickers! If you simply want to sign up and then immediately cancel for “entertainment” — and you have no intent of checking this out to really make money — then click away from this page now…

But if you are serious... if you are interested in learning about opportunities where you trade a small amount of risk to make the biggest fortune you’ve ever seen… then I’m going put everything on a silver platter for you.

In this no-nonsense guide, I’ve laid out everything for you in plain, easy-to-read English. Including:

• The complete story behind why the FDA’s scheduling of clinical testing and approvals allows you the chance to make systematic profits…

• Why these pre-scheduled dates can indicate HUGE upward stock movements months before they happen…

• Why trading around these dates can reduce your overall risk exposure by 25–50%...

• Why you should NEVER trade in front of these dates without having a certain secret, proprietary timing indicator on your side…

• The biggest mistake amateur investors make trying to capture profits from these situations…

• Why it’s possible to get triple-digit returns from these dates — without using options...

• And three other incredible finely tuned strategies to play the RED-HOT biotech market…

You’ll get instant access to The FDA Trader’s Bible  for FREE today… as well as:

• A full year of Flash Alerts and Weekly Updates from me, sent right to your email whenever I recommend that it’s time to make a trade. You get complete Buy and Sell instructions for every play, so you’ll never be left sitting around wondering what to do. These are quick and to-the-point emails you can rely on for the straight story.

• You’ll also get members-only Special Reports, so when there’s urgent information about an FDA trading situation, you’ll have all the details you need. These reports cover the deep science, testing, trial results and business plans, and they give you spot-on buying instructions so you can make the best investing decision for your situation.

You’ll get everything you need to make explosive gains in the biotech and medical device markets as soon as you click the “Subscribe Now” button below.

I’ve made following my recommendations as simple as possible…

It’s as Easy as 1-2-3

In fact, I’ve put the whole thing in an easy-to-use package…

That’s why it doesn’t matter if you are clueless about biotech, the FDA approval process or the latest Nobel Prize-winning medical breakthroughs…

There won’t be any hard-to-understand medical terminology. No science lectures. In fact, there won’t be much about the science of the medicines at all.

Regular folks just like you — not scientists, doctors or Ph.D. researchers — have profited over and over again from FDA Trader recommendations.

Here’s a few quick examples of the happy readers I’ve helped recently:

These are just a few of the hundreds of success stories I’ve received over the past few years by consistently recommending biotech firms that jump 50%... 100%... 200%... and higher.

Recommendations like:

• Synergy Pharma… up 155% in less than six months

• Elixis… which produced a 139% gain

• Anthera Pharmaceuticals… up 127% in just over one month

• AVEO Pharmaceuticals… up 267% in about five months

• And many more…

Discovering these types of gains for yourself using my FDA Trader research service couldn’t be easier…

• First… read my special early-investor “prospectus” called  The Secrets of Profiting From the Ultimate Health Consumer Product… and find out how you can cash in on Phil Summers’ latest venture that will revolutionize medicine and potentially put a “Universal Cure Machine” in every home in America…

• Second… start watching your email. At least once a month, I’ll send you a new trading recommendation in the biotech and medical device sectors. Each one of these will pinpoint a lucrative opportunity with specific buying dates based around FDA approval dates.

• I fully anticipate that dozens more “early stage” opportunities will begin to materialize in the biotech and medical device markets (both in the public and private markets)… and you’ll be one of the first folks to get all the information you’ll need to make the most money possible.

• Third… if they look good to you too, make your plays, get in, get out and position yourself to collect your cash.

That’s it. It couldn’t be much simpler.

Now, you’re probably wondering how much my “all-inclusive” FDA Trader research advisory service costs?

And I can tell you that ordinarily, a full 12-month subscription costs $3,000.

Also, I typically offer a money-back guarantee, just for trying out my service…

That way you can read over all of the information I’ll be sending you… make a few trades based off of my recommendations… and decide if investing in biotech is right for you.

But given the small size of today’s opportunity — a tiny consumer health biotech firm that’s one of the smallest single companies I’ve ever recommended — I’m forced to offer you something even better…

First, I’m giving you a special discounted price for a full subscription to FDA Trader, which you can see by clicking the “Subscribe Now” button.

You can then use that money to build equity in any of my recommendations you like.

And then, in exchange for a typical money-back offer, I’m also going to offer you a two-pronged guarantee instead…

My Two-Pronged Guarantee for Today ONLY

Again, I believe prices could go up way more than that…

But 200% gains should be the absolute minimum if all goes as I expect. And beyond that, I could easily see the market value of this stock explode to 500%, or even larger over a longer term…

But if you don’t at least TRIPLE your money, you’ll get another year of my research service at no charge.

And by the way, this guarantee even applies to paper traders.

If you simply follow along with this recommendation by paper trading, and you still don’t see that 200% gains were possible by the end of the year — you will also receive this complimentary year.

Now, I must repeat…

This opportunity is for serious readers only.

We’re not able to give you your subscription price back here.

So if the idea of a “no-money-back” refund policy scares you…

And if you’re not serious today, then I’d recommend you forego learning about all these cutting-edge ideas through my service and just stick with an index fund that returns 5–10% a year.

But if you’re serious… if you understand that extraordinary reward comes only to the people willing to embrace the risks involved…

And if you hold the ethics needed to keep this information to yourself and NOT share it with others…

Then it sounds like we’re a match — and I promise to do everything I can to make sure that every single person who signs up gets their money’s worth...

Remember: Phil Summers has done this before! At least two times already, he’s run this same “playbook” — creating millions of dollars for early-stage investors.

If there is anyone on Earth who knows how to turn cutting-edge medical science into a mass consumer product, it is Phil.

His latest product is a virtual “Universal Cure Machine” that will help all of us manage our health better, so we can live longer, healthier lives!

Phil has put up his capital and sunk millions of his own money into this project. He owns all the key patents. He’s close to securing “Gold Seal” approval from the FDA to roll this product out to a mass market…

Now it’s up to you.

Are you ready to join him for possibly a million-dollar payout — or more?

Are you in… or out?

Click the link below to get started today…

Sincerely,

Ray Blanco

Chief Technology Analyst,

Agora Financial Editor,

Agora Financial’s FDA Trader

November 2016